Letter to the Editor| Volume 349, ISSUE 1-2, P260-261, February 15, 2015

Clinical utility of triptans in the management of headache attributed to dural arteriovenous fistula involving the cavernous sinus

Published:January 14, 2015DOI:


      • Triptans may be effective in alleviating headache attributable to dural arteriovenous fistula involving the cavernous sinus.
      • Pregabalin may represent a good therapeutic choice for pain due to paradoxical worsening after embolization for cavernous sinus dural arteriovenous fistula.
      • The diagnosis of dural arteriovenous fistula involving the cavernous sinus should be considered in the face of facial pain intractable to conventional medical therapy.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Miller N.R.
        Diagnosis and management of dural carotid-cavernous sinus fistulas.
        Neurosurg Focus. 2007; 23 ([Epub 2007/11/17]): E13
        • Edvinsson L.
        • Uddman E.
        • Wackenfors A.
        • Davenport A.
        • Longmore J.
        • Malmsjo M.
        Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
        Clin Sci (Lond). 2005; 109 ([Epub 2005/04/28]): 335-342
        • Amin F.M.
        • Asghar M.S.
        • Hougaard A.
        • Hansen A.E.
        • Larsen V.A.
        • de Koning P.J.
        • et al.
        Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study.
        Lancet Neurol. 2013; 12 ([Epub 2013/04/13]): 454-461
        • Levy D.
        • Jakubowski M.
        • Burstein R.
        Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists.
        Proc Natl Acad Sci U S A. 2004; 101 ([Epub 2004/03/16]): 4274-4279
        • Jung K.H.
        • Kwon B.J.
        • Chu K.
        • Noh Y.
        • Lee S.T.
        • Cho Y.D.
        • et al.
        Clinical and angiographic factors related to the prognosis of cavernous sinus dural arteriovenous fistula.
        Neuroradiology. 2011; 53 ([Epub 2010/12/17]): 983-992
        • Verma V.
        • Singh N.
        • Singh Jaggi A.
        Pregabalin in neuropathic pain: evidences and possible mechanisms.
        Curr Neuropharmacol. 2014; 12 ([Epub 2014/02/18]): 44-56
        • Mercadante S.
        Gabapentin in painful ophthalmoplegia.
        J Pain Symptom Manage. 2002; 24 ([Epub 2002/11/30]): 288-289
        • Atri A.
        • Sheen V.
        Cavernous sinus syndrome and headache due to bilateral carotid artery aneurysms.
        Arch Neurol. 2003; 60 ([Epub 2003/09/17]): 1327-1328
        • Marinkovic S.
        • Gibo H.
        • Vucevic R.
        • Petrovic P.
        Anatomy of the cavernous sinus region.
        J Clin Neurosci. 2001; 8 ([Epub 2001/06/02]): 78-81